What top creators are saying about Neuralink(PRIVATE)

Presented as a speculative human-computer-interface project, but the discussion provides no product, revenue, valuation, or timeline details.

The discussion raised questions about the scalability and consumer adoption of surgically implanted chips, while suggesting non-invasive devices could have an easier path to a broad market.

The company was mentioned as training a foundation model on neural recordings, part of a broader discussion of potential medical and consumer BCI applications.

Cited as working on brain-related technologies, including efforts to help people with spinal injuries regain movement; the area is described as high-potential but early-stage.

Discussed as pursuing technologies that may help people with spinal injuries regain movement. The broader field is promising, but implantable devices carry technical, ethical, and oversight uncertainties; no investment recommendation or financial details were provided.

Cited as an ambitious technology venture, while the discussion questioned prioritizing space and technology ambitions over problems on Earth; no valuation or recommendation was provided.

Neuralink was mentioned as holding a small amount of Bitcoin, with no figure or specific investment recommendation provided.

Cited as a company working on brain-computer interfaces, including potential vision restoration or augmentation; commercial success and clinical outcomes are uncertain.

Viewed as a long-term play on human augmentation, though it faces significant future regulatory and social hurdles.

Viewed as a 'cheat code' for paralysis and a gateway to human-AI convergence and telepathic communication.

Highlighted as a future leader in human-machine interface (HMI) to allow humans to remain competitive against AI.

Currently lagging behind Chinese competitors in commercial approval despite high brand recognition.

Secondary market valuation surged 344% following FDA breakthrough designations for vision and hearing devices.

Highlighted as a key player in hardware that actively modifies the nervous system, despite its invasive nature.

Positioned as the 'final frontier' in BCI and considered the closest to a consumer device in this advanced category, with successful patient trials.